Amorphical Ltd Information

A Pioneering Israeli Biotech company developing and manufacturing novel pharmaceutical products based on a unique form of calcium: Amorphous Calcium Carbonate (ACC) Inspired by the ability of the Australian Blue Crayfish to shed and regrow its exoskeleton in only three days, Amorphical scientists have demonstrated ACC’s safety, efficacy and high bio availability, and were able to develop a proprietary synthetic form of ACC. This NEW calcium-based therapeutics can become the most effective tool for treating: Osteoporosis Hypoparathyroidism A range of other calcium-related diseases. Company’s R&D continues to expand a variety of pharmaceutical applications, including osteoporosis, hypoparathyroidism, and cancer-related bone